Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries-Reference-Cited by-同舟云学术

Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries

Published:2016-05-24 Issue:21 Volume:133 Page:2076-2085
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Wirtz Veronika J.¹,Kaplan Warren A.¹,Kwan Gene F.¹,Laing Richard O.¹

Affiliation:

1. From Department of Global Health, School of Public Health (V.J.W., W.A.K., R.O.L.) and Section of Cardiovascular Medicine, Department of Medicine (G.F.K.), Boston University School of Medicine, Boston University, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference73 articles.

1. Access to medicines from a health system perspective

2. The Global Burden of Ischemic Heart Disease in 1990 and 2010

3. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

4. Global Status Report on Noncommunicable Diseases 2010. Geneva Switzerland: World Health Organization; 2011.

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical intervention for hypertension in a rural district of the Republic of Zambia: a model-based economic evaluation;BMJ Open;2024-09

2. Managing diabetes and hypertension in western Kenya: A qualitative study of experiences of patients supported by the primary health integrated care for chronic conditions (PIC4C) model of care;PLOS Global Public Health;2024-08-15

3. The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias;Journal of Clinical Medicine;2024-07-16

4. Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition;Advanced Therapeutics;2024-06-26

5. The possibility of calculating optimal doses in combined medicinal product (Working hypothesis);Pharmacokinetics and Pharmacodynamics;2024-06-25